SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

被引：0
|
作者：
C. Kratochwil
M. Stefanova
E. Mavriopoulou
T. Holland-Letz
A. Dimitrakopoulou-Strauss
A. Afshar-Oromieh
W. Mier
U. Haberkorn
F. L. Giesel
机构：
[1] University Hospital Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Biostatistics
[3] German Cancer Research Center,KKE Nuclear Medicine
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Neuroendocrine tumors; Peptide-related radionuclide therapy; [; Ga]DOTATOC; Somatostatin receptor; SUV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 318
页数：5
相关论文
共 50 条
  • [1] SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
    Kratochwil, C.
    Stefanova, M.
    Mavriopoulou, E.
    Holland-Letz, T.
    Dimitrakopoulou-Strauss, A.
    Afshar-Oromieh, A.
    Mier, W.
    Haberkorn, U.
    Giesel, F. L.
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) : 313 - 318
  • [2] SUV of 68Ga-DOTATOC PET/CT predicts response probability of PRRT in neuroendocrine tumors
    Stefanova, Melsa
    Kratochwil, Clemens
    Mavriopoulou, Elena
    Afshar-Oromieh, Ali
    Mier, Walter
    Schwartz, Lawrence
    Haberkorn, Uwe
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [3] [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
    Barbara Gehler
    Frank Paulsen
    Mehmet Ö Öksüz
    Till-Karsten Hauser
    Susanne M Eschmann
    Roland Bares
    Christina Pfannenberg
    Michael Bamberg
    Peter Bartenstein
    Claus Belka
    Ute Ganswindt
    Radiation Oncology, 4
  • [4] [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
    Gehler, Barbara
    Paulsen, Frank
    Oeksuez, Mehmet Oe
    Hauser, Till-Karsten
    Eschmann, Susanne M.
    Bares, Roland
    Pfannenberg, Christina
    Bamberg, Michael
    Bartenstein, Peter
    Belka, Claus
    Ganswindt, Ute
    RADIATION ONCOLOGY, 2009, 4
  • [5] Impact of 68Ga DOTATOC PET/CT in the Therapeutic Management of Neuroendocrine Tumors
    Pilati, E.
    Finessi, M.
    Passera, R.
    De Angelis, C. G.
    Arvat, E.
    Birocco, N.
    Brizzi, M. P.
    Campra, D.
    Giraudo, G.
    Bello, M.
    Bisi, G.
    Deandreis, D.
    NEUROENDOCRINOLOGY, 2019, 108 : 225 - 225
  • [6] Impact of 68Ga DOTATOC PET/CT in the Therapeutic Management of Neuroendocrine Tumors
    Pilati, E.
    Finessi, M.
    Passera, R.
    Liberini, V.
    De Angelis, C. G.
    Arvat, E.
    Piovesan, A.
    Gallo, M.
    Ciuffreda, L.
    Birocco, N.
    Brizzi, M. P.
    Campra, D.
    Giraudo, G.
    Bello, M.
    Bisi, G.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S547 - S548
  • [7] Comparison of (68GA)-Dotatoc-PET and (111IN)-Dtpaoc (Octreoscan ®)-Spect in patients with neuroendocrine tumors
    Buchmann, I.
    Engelbrecht, S.
    Henze, M.
    Eisenhut, M.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S192 - S192
  • [8] Comparison of 68Ga DOTATOC PET/CT with morphological imaging in staging of neuroendocrine tumors
    Finessi, M.
    Pilati, E.
    Passera, R.
    Liberini, V.
    De Angelis, C.
    Arvat, E.
    Birocco, N.
    Brizzi, M.
    Campra, D.
    Giraudo, G.
    Bello, M.
    Bisi, G.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S541 - S541
  • [9] [68Ga]-DOTATOC PET/CT in myocardial metastases of neuroendocrine neoplasms
    Yiraldine Herrera-Martínez
    José Luis Vercher-Conejero
    Juan José Martín-Marcuartu
    Alex Telué Vega
    Fernando Guerrero-Pérez
    Montserrat Cortés Romera
    Journal of Nuclear Cardiology, 2023, 30 : 1706 - 1708
  • [10] Clinical efficacy of 68Ga - DOTATOC-PET/CT for restaging in renal cell carcinoma
    Nakamoto, Yuji
    Ishimori, Takayoshi
    Shimizu, Yoichi
    Sano, Kohei
    Togashi, Kaori
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
12345